Delivery Order SPE2DE24D0013-SPE2D625F1MUC
- Not listed
- The U.S. Defense Logistics Agency, operating under its Medical Supply Chain division, awarded a $4,488 firm fixed-price delivery order to Cepheid Inc. on September 25, 2025, with an ultimate completion date of October 9, 2025. The contract, designated as SARS-COV-2 FLU RSV 10S, procures molecular diagnostic testing solutions from the Sunnyvale, California-based manufacturer. This delivery order carries no set-aside designation and represents a discrete procurement under Cepheid's broader federal...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain function, awarded a $20.4K firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with a completion date of September 25, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) testing, with performance to be executed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $2,244 firm fixed-price delivery order to Cepheid Inc. on August 28, 2025, for SARS-CoV-2, Flu, and RSV molecular diagnostic testing solutions. The contract, which contains no set-aside designation, carries an ultimate completion date of September 12, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order is part of Cepheid's broader federal contracting...
- The U.S. Defense Logistics Agency awarded a $29,478.60 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 6, 2025, with an ultimate completion date of August 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a relatively modest...
- The U.S. Defense Department's Medical Supply Chain awarded a $204,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 22, 2025, and carries no set-aside designation. This award represents a continuation of the department's partnership with Cepheid to procure diagnostic testing solutions, specifically for...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $6,468.30 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, covers diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The award carries no set-aside designation and represents a task order under...
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1MUCDelivery Order
The U.S. Defense Logistics Agency (Medical Supply Chain division) awarded a $4,488 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 21, 2025. The delivery order, valued at $4,488 with an ultimate completion date of September 5, 2025, is for SARS-CoV-2, Flu, and RSV testing solutions. This award utilizes no set-aside designation and represents a continuation of Cepheid's longstanding partnership with federal healthcare systems to provide rapid molecular diagnostic capabilities for infectious diseases. This delivery order is likely associated with Cepheid's broader federal contracting relationships, including significant indefinite delivery vehicles with the Veterans Integrated Service Networks valued in the millions of dollars that support ongoing procurement of molecular diagnostic testing systems and reagents. Cepheid's expertise in GeneXpert diagnostic systems and PCR-based testing platforms positions the company as a key supplier for infectious disease detection across federal agencies, supporting critical pandemic preparedness and routine clinical diagnostics for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 8/21/25 |